Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Cooper Companies (The) (COO)

NASDAQ: COO · Health Care Supplies · San Ramon, CA

Our rating: Neutral

Neutral reaffirmed at $54.61, moderate conviction, September 16, 2026.

Breaks if: The Neutral call turns Cautious if revenue growth decelerates below 3% on a trailing-twelve-month basis within the next four quarters, or if the net margin compresses below 7.5% without a corresponding lift in free cash flow — signaling that the amortization burden is worsening rather than simply persisting. It turns Positive if revenue growth reaccelerates above 8% year-on-year for two consecutive quarters, or if the stock pulls back enough that the FCF yield rises above 5.5% — implying a price at or below roughly $44 on current earnings.

Key figures

Market value$11.2B
Revenue, last 12 months$4.2B
Net income, last 12 months$570M
Free cash flow, last 12 months$678M
Price to earnings19.6×
Free cash flow yield6.1%
Dividend yield0.0%
Operating margin12.8%
Return on equity6.8%
Beta to the S&P 5000.63
Volatility, annualized32.5%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
July 31, 2026$1.1B0.6%$2.24$273M
April 30, 2026$1.1B7.9%$-0.40$96M
January 31, 2026$1.0B6.2%$0.66$159M
October 31, 2025$1.1B4.6%$0.42$150M
July 31, 2025$1.1B5.7%$0.49$165M
April 30, 2025$1.0B6.3%$0.44$18M
January 31, 2025$965M3.6%$0.52$101M
October 31, 2024$1.0B9.8%$0.59$128M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

9 ledger entries and 59 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.